Form 4 for DGX Quest Diagnostics
Accepted 2025-09-30 00:00:00 ET · period of report 2025-09-26 · accession 0001022079-25-000203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-30 | 2025-09-26 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | +227 | 38.3K | +0.6% | +$23.5K |
| DM | 2025-09-30 | 2025-09-26 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $188.13 | -227 | 38.1K | -0.6% | -$42.7K |
| D | 2025-09-30 | 2025-09-26 | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | -227 | 0 | -100% | -$23.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-26 | M | A | 227 | $103.57 | 38,344 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-26 | S | D | 83 | $187.22 | 38,261 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $187.00 to $187.480. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-09-26 | S | D | 144 | $188.66 | 38,117 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $188.220 to $189.080. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2025-09-26 | M | D | 227 | $103.57 | 0 | D | $103.57 · — to 2028-02-19 | 227 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021. |